
David Siegel, MD, MPH
Advertisement
Articles by David Siegel, MD, MPH

Advertisement
Latest Updated Articles
Renal Effects of Angiotensin-Converting Enzyme Inhibitors That Result in Cost Savings and Improved Patient OutcomesPublished: March 1st 2001 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
TrumpRx Launch Brings Savings—and Uncertainty
2
How Do GLP-1 Agonists Fit Into Stroke Care?
3
Aligning Treatment Goals in IgA Nephropathy: Applying KDIGO’s Dual-Pathway Framework to Clinical Decision-Making
4
Addressing Disparities at Every Step of the Stroke Care Pathway: Luke Messac, MD, PhD
5



